The Safety and Efficiency of Tirofiban in Acute Ischemic Stroke Patients Treated with Mechanical Thrombectomy: A Multicenter Retrospective Cohort Study

Table 4

Multivariate regression analysis to determine the influence of tirofiban on safety and efficacy outcomes.

Outcome	aOR	95% CI	value
Efficiency outcomes
END^a	1.22	0.54–2.72	0.63
Neurological improvement at 7 d^b	1.02	0.49–2.12	0.951
mRS ≤ 2 at 3^th month^c	1.54	0.69–3.45	0.296
mRS ≤ 2at 9^th month^d	1.22	0.61–2.46	0.577
Safety outcomes
ICH^e	0.57	0.28–1.16	0.122
Death at 9^th month^f	0.840	0.39–1.79	0.652

AOR: adjusted OR. ^aAdjusted operative period antiplatelet, TICI. ^bAdjusted operative period antiplatelet, median SBP in 24 h,. ^cAdjusted dehydration, NIHSS on admission, operative period antiplatelet, sedative. ^dAdjusted NIHSS on admission, operative period antiplatelet. ^eAdjusted anterior circulation stroke, dehydration, operative period antiplatelet. ^fAdjusted dehydration, anterior circulation stroke, and operative period antiplatelet.